Most manufacturers approach a new market in the same order: find a distributor, sign an agreement, ship the first pallet and wait for sales. In Uzbekistan that order costs time. Registration timelines depend on the product class, and a distributor cannot sell what is not yet approved — so the first months are spent on paperwork that could have started much earlier.
Start with the product, not with the contract
Before the first meeting it is worth answering three questions: which class does the product belong to, which documents already exist in the manufacturer's dossier, and which of them will need translation, legalisation or additional testing. The answers determine everything that follows — the realistic launch date, the size of the first shipment and the price the market will see.
Registration runs in parallel, not after
A registration dossier is assembled from documents the manufacturer already has: certificates of the quality system, product specifications, clinical and safety data, labelling and instructions for use. Gaps in this set are the usual reason for delay, and they are far cheaper to close before submission than after a request from the regulator.
While the dossier is under review, the commercial side can already move: pricing model, warehouse requirements, the list of clinics to approach first, the training plan for the launch quarter.
The first shipment is a test, not a target
A first order sized for optimism is a common mistake. Aesthetic products have shelf life, storage requirements and a seasonal demand curve. A modest first shipment with a fast replenishment cycle tells more about real demand than a large one that sits in a warehouse.
Physicians decide adoption
In aesthetic medicine the buyer and the user are the same person, and that person needs to be confident with the product in their own hands. Practitioners choose what they have injected, applied or worked with under supervision. A launch without a training programme is a launch that depends entirely on price.
- hands-on sessions with a small group instead of a large lecture;
- local key opinion leaders who continue using the product afterwards;
- protocols and aftercare materials in Russian and Uzbek;
- a follow-up channel for questions after the training.
Sell-out is what counts
Sell-in — the volume shipped to a distributor — says nothing about the position of a brand. Sell-out does: how many units left the shelf, in which clinics, how often the same clinic reorders. Reporting on that level shows whether the launch is working long before the annual figures do.
The sequence itself is not complicated. It is the parallel work — regulatory, commercial and educational at the same time — that shortens the path from the first call to steady demand.